贝林司他(商标是Beleodaq,以前称为PXD101)是TopoTarget开发的用于治疗血液恶性肿瘤和实体肿瘤的组蛋白去乙酰化酶抑制剂。

清空选项
63555-50-0

BD3444563555-50-096%

¥227.501g常备现货

163487-10-3

BD627889163487-10-397%

¥557.00250mg常备现货

99-61-6

BD3557299-61-697%

¥64.00100g常备现货

2905-24-0

BD98022905-24-097%

¥40.005g常备现货

5927-18-4

BD1554445927-18-498%

¥33.0010g常备现货

166338-06-3

BD317430166338-06-395+%

¥暂无

866323-86-6

BD304964866323-86-695+%

¥997.00250mg

610801-82-6

BD249626610801-82-695+%

¥2785.001g

5330-48-3

BD2473465330-48-395+%

¥7862.405g

1137621-29-4

BD6334951137621-29-497%

¥暂无

17625-03-5

BD8919717625-03-595%

¥64.0025g

659-04-1

BD627888659-04-198%

¥1024.00100mg

866323-87-7

BD629798866323-87-797%

¥5304.00100mg

610801-83-7

BD249627610801-83-795+%

¥3376.001g

1